RxDoctor Payments Data

William Jennings

Internal Medicine · San Antonio, TXNPI 1790012276

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,351 of the $2,013 with a category attached, or 67.1%. AbbVie accounts for 85.8% of it on its own, with 1 other manufacturer making up the rest.

$2,013in general payments, 2019–2025

Across 15 payments — averaging $134.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Merck$286
$2,542,398in research payments, 2019–2025

Across 662 payments — averaging $3840.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$1.2M
  • Sanofi Pasteur Inc.$372K
  • Janssen Research & Development, LLC$351K
  • Merck$319K
  • AbbVie$245K
  • Akcea Therapeutics, Inc.$55K
  • plus $14K from 7 others

What the payments were for

  • Travel & lodging$1,35167%
  • Food & beverage$66233%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie9$1,727
Merck6$286

How this compares

$2,013 in reported general payments places this provider in the 75th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas →

Other internal medicine in San Antonio

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →